Work

Imatinib Mesylate (Gleevec®) Is Active in Relapsed/Refractory Waldenstrom’s Macroglobulinemia: Planned Interim Results of WMCTG Clinical Trial 05-140.

Year: 2006

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v108.11.2484.2484

Authors: Steven P. Treon, Jacob D. Soumerai, Christopher J. Patterson, Zachary R. Hunter, Rose Villarreal, Irene M. Ghobrial

Institutions: Harvard University, Dana-Farber Cancer Institute

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2515522281

FWCI: 0.292

Cites:

Cited by: 3

Related to: 10